OSTX
OS Therapies Inc
Company overview
- Market capitalization
- $76.11M
- Employees
- 4
- Latest publication
- 2026-09-29
About OS Therapies Inc
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 124,938USD | 124,938USD | 124,938USD | 112,514USD | 695USD | 1,390USD | — | 695USD |
| Gross Profit | -124,938USD | -124,938USD | -124,938USD | -112,514USD | -695USD | -1,390USD | — | -695USD |
| Research Development | 7,226,785USD | 16,353,286,645USD | 3,755,335USD | 2,499,498USD | 1,309,155USD | 869,079USD | 1,210,216USD | 396,567USD |
| Selling General Administrative | 2,816,215USD | 12,342,636,770USD | 3,124,260USD | 2,339,230USD | 3,690,331USD | 2,095,955USD | 1,227,177USD | 383,233USD |
| Total Operating Expenses | 10,043,000USD | 11,862,954USD | 6,879,595USD | 4,726,214USD | 4,999,486USD | 2,965,034USD | 2,437,393USD | 779,800USD |
| Operating Income | -10,167,938USD | -11,987,892USD | -6,879,595USD | -4,838,728USD | -4,999,486USD | -2,966,424USD | -2,437,393USD | -779,800USD |
| Interest Income | 45USD | 54USD | 65USD | 64USD | 66USD | 1USD | 0USD | 1USD |
| Interest Expense | 75,344USD | 0USD | 0USD | 0USD | 0USD | 7,556USD | 437,839USD | 777,681USD |
| Net Interest Income | -75,299USD | 54USD | 65USD | 64USD | 66USD | -7,557USD | -437,839USD | -777,680USD |
| Income Before Tax | -10,396,831USD | -13,460,833USD | -6,879,530USD | -4,536,622USD | -3,876,859USD | -2,991,234USD | -2,875,232USD | -1,557,480USD |
| Net Income | -10,396,831USD | -13,460,833USD | -6,879,530USD | -4,536,622USD | -3,876,859USD | -2,991,234USD | -2,875,232USD | -1,557,480USD |
| Net Income From Continuing Ops | -10,396,831USD | -13,460,833USD | -6,879,530USD | -4,536,622USD | -3,876,859USD | -2,991,234USD | -2,875,232USD | -1,557,480USD |
| Ebit | -10,321,487USD | -13,460,833USD | -6,879,530USD | -4,536,622USD | -3,876,859USD | -2,983,674USD | -2,437,393USD | -779,799USD |
| Ebitda | -10,196,549USD | -13,335,895USD | -6,754,592USD | -4,424,108USD | -3,876,164USD | -2,982,284USD | -2,099,104USD | -779,104USD |
| Depreciation And Amortization | 124,938USD | 124,938USD | 124,938USD | 112,514USD | 695USD | 1,390USD | 338,289USD | 695USD |
| Reconciled Depreciation | 124,938USD | 124,938USD | 124,938USD | 112,514USD | 695USD | 1,390USD | 0USD | 695USD |
| Total Other Income Expense Net | -228,893USD | -1,472,941USD | 65USD | 302,106USD | 1,122,627USD | -24,810USD | -437,839USD | -777,680USD |
| Unclassified Operating Expenses | — | -28,684,060,461USD | — | — | — | — | — | — |
| Other Operating Expenses | — | — | — | — | — | — | — | 779,800USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 363,085USD | 2,780USD | 4,220USD | 805USD | 1,159,642USD | 4,250USD |
| Gross Profit | -363,085USD | -2,780USD | -4,220USD | -805USD | -1,159,642USD | -4,250USD |
| Research Development | 16,360,725,000USD | 2,836,280USD | 3,216,933USD | 3,291,417USD | 2,174,179USD | 602USD |
| Selling General Administrative | 12,344,976,000USD | 3,974,786USD | 1,120,560USD | 1,153,672USD | 1,503,534USD | 795USD |
| Unclassified Operating Expenses | -28,677,358,384USD | — | — | — | — | — |
| Total Operating Expenses | 28,342,616USD | 6,811,066USD | 4,342,647USD | 4,446,299USD | 3,677,713USD | 1,397USD |
| Operating Income | -28,705,701USD | -6,813,846USD | -4,342,647USD | -4,446,299USD | -4,837,355USD | -5,647USD |
| Interest Income | 249USD | 0USD | 2USD | 0USD | — | — |
| Interest Expense | 0USD | 2,051,839USD | 3,448,939USD | 1,808,386USD | 2,582,893USD | 461,785,000USD |
| Net Interest Income | 249USD | -2,051,839USD | -3,448,937USD | -1,808,386USD | -2,582,893USD | — |
| Income Before Tax | -28,753,844USD | -8,882,938USD | -7,791,584USD | -6,254,685USD | -7,420,248USD | -6,027USD |
| Net Income | -28,753,844USD | -8,882,938USD | -7,791,584USD | -6,254,685USD | -7,420,248USD | -6,027USD |
| Net Income From Continuing Ops | -28,753,844USD | -8,882,938USD | -7,791,584USD | -6,254,685USD | -7,420,248USD | — |
| Ebit | -28,753,844USD | -6,831,096USD | -4,342,645USD | -4,446,299USD | -4,837,355USD | -5,647USD |
| Ebitda | -28,390,759USD | -6,828,316USD | -4,338,425USD | -4,445,494USD | -4,836,550USD | 61,353USD |
| Depreciation And Amortization | 363,085USD | 2,780USD | 4,220USD | 805USD | 805USD | 67,000USD |
| Reconciled Depreciation | 363,085USD | 2,780USD | 4,220USD | 805USD | 805USD | — |
| Total Other Income Expense Net | -48,143USD | -2,069,092USD | -3,448,937USD | -1,808,386USD | -2,582,893USD | -381USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,897,313USD | 7,299,236USD | 6,839,534USD | 8,953,251USD | 10,310,475USD | 4,249,931USD | 5,538,797USD | 1,977,264USD |
| Total Current Assets | 3,640,567USD | 917,552USD | 332,912USD | 2,321,691USD | 3,553,976USD | 4,095,356USD | 5,533,527USD | 1,970,604USD |
| Total Liabilities | 20,741,243USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 20,641,243USD | 16,952,769USD | 11,764,460USD | 4,145,351USD | 3,458,034USD | 3,536,265USD | 4,627,310USD | 2,584,391USD |
| Total Stockholder Equity | -11,914,635USD | -10,824,238USD | -6,095,631USD | 4,707,900USD | 6,752,441USD | -4,186,578USD | 811,487USD | -707,127USD |
| Total Equity Including Noncontrolling Interest | -10,843,930USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,100USD | 1,795USD | 2,490USD | 3,185USD | 3,880USD | 4,575USD | 5,270USD | 6,660USD |
| Accounts Payable | 20,247,881USD | 15,233,838USD | 9,936,387USD | 3,374,287USD | 2,702,724USD | 1,616,390USD | 1,662,068USD | 1,771,965USD |
| Common Stock | 45,283USD | 39,278USD | 37,116USD | 33,270USD | 29,665USD | 21,348USD | 20,870USD | 21,181USD |
| Retained Earnings | -86,215,436USD | -77,583,050USD | -67,186,219USD | -53,725,386USD | -46,845,856USD | -42,309,234USD | -40,404,350USD | -35,441,141USD |
| Intangible Assets | — | 6,379,889USD | 6,504,132USD | 6,628,375USD | 6,752,619USD | 150,000USD | — | — |
| Other Current Assets | — | -916,634,448USD | 63,082USD | 445,065USD | 751,963USD | 1,124,349USD | — | 112,500USD |
| Total Liab | — | 18,123,474USD | 12,935,165USD | 4,245,351USD | 3,558,034USD | 8,436,509USD | 4,727,310USD | 2,684,391USD |
| Other Current Liab | — | 375,989USD | 1,828,073USD | 771,064USD | 755,310USD | 1,919,875USD | 2,965,242USD | 812,426USD |
| Capital Stock | — | 39,278USD | 37,116USD | 33,270USD | 29,665USD | 21,348USD | 6,070,870USD | 21,181USD |
| Cash | — | 917,552USD | 269,830USD | 1,876,626USD | 2,802,013USD | 2,971,007USD | 5,533,527USD | 1,858,104USD |
| Cash And Short Term Investments | — | 917,552USD | 269,830USD | 1,876,626USD | 2,802,013USD | 2,971,007USD | 5,533,527USD | 1,858,104USD |
| Net Debt | — | 425,390USD | -269,830USD | -1,876,626USD | -2,802,013USD | -2,971,007USD | -5,533,527USD | -1,858,104USD |
| Short Term Debt | — | 1,342,942USD | — | — | — | — | — | — |
| Short Long Term Debt | — | 1,342,942USD | — | — | — | — | — | — |
| Short Long Term Debt Total | — | 1,342,942USD | — | — | — | — | 6,050,000USD | — |
| Common Stock Shares Outstanding | — | 38,674,663shares | 29,253,000shares | 31,956,686shares | 25,114,460shares | 21,249,423shares | 123,772,990shares | 15,897,460shares |
| Non Current Assets Total | — | 6,381,684USD | 6,506,622USD | 6,631,560USD | 6,756,499USD | 154,575USD | 5,270USD | 6,660USD |
| Non Current Liabilities Total | — | 1,170,705USD | 1,170,705USD | 100,000USD | 100,000USD | 4,900,244USD | 100,000USD | 100,000USD |
| Non Currrent Assets Other | — | -1,793,205USD | -2,487,510USD | 6,628,375,000USD | 0USD | 150,000,000USD | 0USD | — |
| Net Working Capital | — | -16,035,217USD | -11,431,548USD | -1,823,660USD | 95,942USD | 559,091USD | 906,217USD | -613,787USD |
| Unclassified Current Liabilities | — | -1,342,942USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 1,170,705USD | 1,170,705USD | — | — | 4,900,244USD | — | — |
| Unclassified Equity | — | 66,680,256USD | 61,016,356USD | 58,366,746USD | 53,538,967USD | 38,079,960USD | 35,124,097USD | 34,691,652USD |
| Unclassified Non Current Assets | — | — | — | -6,628,375,000USD | — | -150,000,000USD | — | — |
| Net Receivables | — | — | — | — | — | 23,636USD | — | 77,500USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 6,839,534USD | 5,538,797USD | 798,082USD | 509,105USD | 325,891USD | 1,678,011,000USD |
| Intangible Assets | 6,504,132USD | — | — | — | — | — |
| Other Current Assets | 63,082USD | — | 751,050USD | 324,210USD | 956,956USD | 12,800,000USD |
| Total Liab | 12,935,165USD | 4,727,310USD | 24,814,297USD | 18,066,333USD | 11,777,104USD | 8,004,828,000USD |
| Total Stockholder Equity | -6,095,631USD | 811,487USD | -24,016,215USD | -17,557,228USD | -11,451,213USD | -6,326,817,000USD |
| Other Current Liab | 1,828,073USD | 2,965,242USD | 7,388,557USD | 4,496,647USD | 2,272,735USD | 1,231,839,000USD |
| Common Stock | 37,116USD | 20,870USD | 5,340USD | 4,990USD | 9,980USD | 8,835,000USD |
| Capital Stock | 37,116USD | 6,070,870USD | 6,642USD | 6,292USD | 11,282USD | — |
| Retained Earnings | -67,186,219USD | -40,404,350USD | -29,518,187USD | -21,601,603USD | -15,221,918USD | -6,335,652,000USD |
| Cash | 269,830USD | 5,533,527USD | 38,982USD | 171,480USD | 80,788USD | 1,232,776,000USD |
| Cash And Short Term Investments | 269,830USD | 5,533,527USD | 38,982USD | 171,480USD | 80,788USD | 1,232,776,000USD |
| Total Current Assets | 332,912USD | 5,533,527USD | 790,032USD | 496,835USD | 312,815USD | 1,676,064,000USD |
| Total Current Liabilities | 11,764,460USD | 4,627,310USD | 24,714,297USD | 6,147,792USD | 3,496,276USD | 2,103,129,000USD |
| Net Debt | -269,830USD | -5,533,527USD | 14,571,359USD | 10,176,152USD | 6,991,627USD | 5,540,173,000USD |
| Accounts Payable | 9,936,387USD | 1,662,068USD | 2,715,399USD | 1,225,134USD | 856,521USD | 40,000USD |
| Property Plant Equipment Net | 2,490USD | 5,270USD | 8,050USD | 12,270USD | 13,076USD | 1,947,000USD |
| Common Stock Shares Outstanding | 29,253,000shares | 20,869,908shares | 20,049,655shares | 23,100,819shares | 23,100,819shares | 8,422,082shares |
| Non Current Assets Total | 6,506,622USD | 5,270USD | 8,050USD | 12,270USD | 13,076USD | 1,946,999USD |
| Non Current Liabilities Total | 1,170,705USD | 100,000USD | 100,000USD | 11,918,541USD | 8,280,828USD | 5,901,699,000USD |
| Non Currrent Assets Other | -2,487,510USD | 0USD | — | — | — | — |
| Net Working Capital | -11,431,548USD | 906,217USD | -23,924,265USD | -5,650,957USD | -3,183,461USD | — |
| Unclassified Non Current Liabilities | 1,170,705USD | — | — | — | — | 5,901,699,000USD |
| Unclassified Equity | 61,016,356USD | 35,124,097USD | 5,489,990USD | 4,033,093USD | 3,749,443USD | — |
| Short Long Term Debt Total | — | 6,050,000USD | 14,610,341USD | 10,347,632USD | 7,072,415USD | 6,772,949,000USD |
| Short Term Investments | — | 5,527,993,473USD | — | — | — | — |
| Unclassified Current Assets | — | -5,527,993,473USD | — | — | — | — |
| Short Term Debt | — | — | 14,610,341USD | 3,039,054USD | 1,612,054,000USD | 871,250,000USD |
| Short Long Term Debt | — | — | 14,610,341USD | — | — | — |
| Unclassified Current Liabilities | — | — | -14,610,341USD | -2,613,043USD | -1,611,686,980USD | — |
| Long Term Debt | — | — | — | 10,347,632USD | 7,072,415USD | — |
| Net Receivables | — | — | — | 1,145USD | 231,071USD | 430,488,000USD |
| Non Current Liabilities Other | — | — | — | 1,470,909USD | 1,108,413USD | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 249,876USD |
| Stock Based Compensation | 2,766,473USD |
| Change To Account Receivables | -3,097,825USD |
| Change To Liabilities | 8,896,492USD |
| Change In Working Capital | -3,097,825USD |
| Operating Cash Flow | -10,096,410USD |
| Financing Cash Flow | 10,031,615USD |
| Change In Cash | -64,795USD |
| End Cash Flow | 205,035USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,396,831USD | -6,879,530USD | -4,536,622USD | -3,876,859USD | -2,991,234USD | -2,875,232USD | -1,557,480USD | -1,458,992USD |
| Depreciation | 124,938USD | 124,938USD | 112,514USD | 695USD | 1,390USD | 338,289USD | 695USD | 695USD |
| Stock Based Compensation | 1,435,362USD | 814,932USD | 905,182USD | 941,283USD | — | 0USD | 0USD | 0USD |
| Other Non Cash Items | 1,793,534USD | 197,401USD | -292,042USD | -207,738USD | 301,823USD | 322,916USD | 446,527USD | 578,736USD |
| Change In Working Capital | 3,914,821USD | 1,036,067USD | 1,450,714USD | -299,265USD | 313,444USD | -847,855USD | 229,067USD | 237,832USD |
| Total Cash From Operating Activities | -4,563,538USD | -4,706,192USD | -2,360,254USD | -3,441,884USD | -2,374,577USD | -3,384,798USD | -881,191USD | -641,729USD |
| Capital Expenditures | 0USD | -466,423USD | -316,423USD | -150,000USD | -3USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -4,563,540USD | -4,706,192USD | -2,676,677USD | -3,591,884USD | -2,374,580USD | -3,384,798USD | -881,191USD | -641,729USD |
| Net Borrowings | 1,835,000USD | 0USD | 0USD | 0USD | 0USD | -250,000USD | — | — |
| Total Cash From Financing Activities | 5,211,000USD | 3,780,805USD | 2,484,047USD | 1,053,000USD | 6,050,000USD | 5,147,977USD | 875,885USD | 702,978USD |
| Issuance Of Capital Stock | 0USD | -3,537,047USD | 2,484,047USD | 1,053,000USD | 6,050,000USD | 5,225,840USD | 0USD | 0USD |
| Change In Cash | 648,000USD | -925,387USD | -168,994USD | -2,562,520USD | 3,675,423USD | 1,763,179USD | -5,306USD | 61,249USD |
| Begin Period Cash Flow | 269,830USD | 2,802,013USD | 2,971,007USD | 5,533,527USD | 1,858,104USD | 94,925USD | 100,231USD | 38,982USD |
| End Period Cash Flow | 917,552USD | 1,876,626USD | 2,802,013USD | 2,971,007USD | 5,533,527USD | 1,858,104USD | 94,925USD | 100,231USD |
| Other Cashflows From Financing Activities | -260USD | 6,264,270USD | 2,484,047USD | 1,053,000USD | 6,050,000USD | 172,137USD | -24,115USD | -148,022USD |
| Unclassified Operating Cash Flow | -1,435,362USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 3,376,260USD | -6,400,498,465USD | -2,484,047USD | -1,053,000USD | -6,050,000USD | — | — | — |
| Investments | — | 0USD | -292,787USD | -173,636USD | 0USD | 0USD | 0USD | 0USD |
| Total Cashflows From Investing Activities | — | -465,956,577USD | -292,787USD | -173,636USD | — | — | — | — |
| Sale Purchase Of Stock | — | 6,398,015,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | -466,423,000USD | 23,636USD | -23,636USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|
| Net Income | -8,882,938USD | -7,791,584USD | -6,254,685USD | -7,420,248USD |
| Depreciation | 2,780USD | 4,220USD | 805USD | 805USD |
| Stock Based Compensation | 268,300USD | 0USD | — | — |
| Other Non Cash Items | 1,459,202USD | 2,763,147USD | 1,513,970USD | 2,441,964USD |
| Change In Working Capital | -129,639USD | 2,017,250USD | 947,330USD | 574,668USD |
| Total Cash From Operating Activities | -7,282,295USD | -3,006,967USD | -3,792,580USD | -4,402,811USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -11,934USD |
| Free Cash Flow | -7,282,295USD | -3,006,967USD | -3,792,580USD | -4,414,745USD |
| Investments | 0USD | 1,145USD | 230,881USD | 200,473USD |
| Net Borrowings | 1,501,000USD | 3,157,500USD | 3,824,412USD | 2,950,350USD |
| Total Cash From Financing Activities | 12,776,840USD | 2,873,324USD | 3,652,391USD | 3,050,350USD |
| Dividends Paid | -31,250,000USD | — | — | — |
| Issuance Of Capital Stock | 11,275,840USD | 0USD | — | — |
| Change In Cash | 5,494,545USD | -132,498USD | 90,692USD | -1,151,988USD |
| Begin Period Cash Flow | 38,982USD | 171,480USD | 80,788USD | 1,232,776USD |
| End Period Cash Flow | 5,533,527USD | 38,982USD | 171,480USD | 80,788USD |
| Other Cashflows From Financing Activities | 37,300,000USD | -284,176USD | -172,021USD | 100,000USD |
| Unclassified Financing Cash Flow | -6,050,000USD | — | — | — |
| Total Cashflows From Investing Activities | — | 1,145USD | 230,881USD | 200,473USD |
| Other Cashflows From Investing Activities | — | 1,145USD | 230,881USD | 212,407USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.